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The newly identified Middle East respiratory syndrome coronavirus (MERS-CoV), which 
causes severe respiratory disease, particularly in people with comorbidities, requires 
further investigation. Studies in Qatar and elsewhere have provided evidence that 
dromedary camels are a reservoir for the virus, but the exact modes of transmission 
of MERS-CoV to humans remain unclear. In February 2014, an assessment was made 
of the suitability and sensitivity of different types of sample for the detection of MERS-
CoV by real-time reverse-transcription polymerase chain reaction (RT-PCR) for three 
gene targets: UpE (upstream of the E gene), the N (nucleocapsid) gene and open 
reading frame (ORF) 1a. Fifty-three animals presented for slaughter were sampled. 
A high percentage of the sampled camels (79% [95% confidence interval 66.9–91.5%, 
standard error 0.0625]; 42 out of 53) were shown to be shedding MERS-CoV at the time 
of slaughter, yet all the animals were apparently healthy. Among the virus-positive 
animals, nasal swabs were most often positive (97.6%). Oral swabs were the second 
most frequently positive (35.7%), followed by rectal swabs (28.5%). In addition, the 
highest viral load, expressed as a cycle threshold (Ct) value of 11.27, was obtained 
from a nasal swab. These findings lead to the conclusion that nasal swabs are the 
candidate sample of choice for detecting MERS-CoV using RT-PCR technology in 
apparently healthy camels.
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Introduction
Since the identification of Middle East respiratory syndrome 
coronavirus (MERS-CoV) in 2012 as a newly emerging 
disease causing severe lower respiratory tract infection in 
humans, cases have continued to be reported to the World 
Health Organization (WHO) (1). The causative agent, 
MERS-CoV, is a virus with a positive-stranded RNA genome, 
belonging to the genus Betacoronavirus-1 of the family 
Coronaviridae. Diagnosis in humans is based on detection 
of viral RNA by real-time reverse-transcription polymerase 
chain reaction (RT-PCR) in samples from the upper and 
lower respiratory tract, although positive serum samples 
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and stool have occasionally been described (2). Although 
the exact sources and modes of transmission remain to be 
determined, dromedary camels are thought to play a role in 
MERS-CoV epidemiology: a high proportion of dromedary 
camels from regions with human cases and beyond have 
neutralising antibodies to MERS-CoV (3, 4, 5, 6), and virus 
shedding has been detected by RT-PCR and virus isolation 
from apparently healthy animals (7, 8, 9). Viruses isolated 
from camels replicate efficiently in human cells using 
human dipeptidyl peptidase 4 (DPP4) as an entry receptor, 
providing further evidence for the zoonotic potential of 
dromedary MERS-CoV (10). To study the epidemiology of 
MERS-CoV among camels, the shedding of virus by a group 
of 53 camels was studied, in order to determine the optimal 
type of sample for routine screening.
Materials and methods
Animals and sample collection
Fifty-three dromedary camels, Camelus dromedarius, ranging 
in age from four months to 11 years, that were presented 
for slaughter at an abattoir in Doha in February 2014 were 
selected randomly as part of a series of studies to identify 
risk factors for MERS-CoV infection in humans exposed to 
animals with the virus. The camels originated from different 
localities in Qatar, including Al-Shahanyia and Abu-Nakhla, 
and were kept in pens at Doha Central Market. Sample 
collection was done jointly by the Communicable Disease 
Control Team of the Supreme Health Council (CDCT–SHC) 
and the Animal Health Team, Qatar. Personal protective 
biosafety equipment, including N95 masks, disposable 
gowns and gloves, was used during handling of the animals 
and sampling. The animals were restrained by their regular 
caretakers. All samples were collected using FLOQSwabs 
(Copan Improved Diagnostics, Brescia, Italy). Nasal, oral 
and rectal swabs, as well as serum, were collected prior to 
slaughter. The swabs were placed into tubes containing viral 
transport medium-UTM (Universal Transport Medium; 
Copan Diagnostics, Brescia, Italy) (Fig. 1), immediately 
stored at 4°C, and directly transported to the Biotechnology 
Veterinary Laboratory, Qatar Ministry of Environment, 
where they were clarified by low-grade centrifugation after 
vortexing, aliquoted and stored at –80°C until shipment 
on dry ice to the Department of Viroscience Laboratory, 
Erasmus Medical Center, the Netherlands.
RNA isolation and real-time RT-PCR application
Total nucleic acids were isolated from all swabs from 200 μl 
swab medium using the MagnaPure 96 total nucleic acid 
isolation kit (Roche, Mannheim, Germany) with a final 
elution of 50 μl. Camel MERS-CoV RNA was quantified on 
the ABI prism 7700 with the TaqMan Fast Virus 1-Step Master 
Mix (Applied Biosystems, Bleiswijk, the Netherlands) using 
Fig. 1 
Sampling of dromedary camels using the universal viral 
transport system
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10 μl extracted nucleic acid, TaqMan Fast Virus 1-Step mix, 
0.5 U uracil-N-glycosylase, primers and probes targeting 
the UpE (upstream of the E gene), the N (nucleocapsid) 
gene or open reading frame (ORF) 1a, as described (11, 
12). The RNA dilutions isolated from a MERS-CoV isolate 
EMC stock were used as a positive control. The PCR 
amplification involved a reverse transcription step of 50°C 
for 5 min and a denaturation step of 95°C for 20 s, followed 
by 45 cycles of 95°C for 3 s and 60°C for 30 s.
Results
According to international consensus, samples were 
considered positive for MERS-CoV RNA when at least two 
different targets were reactive. In animals up to two years 
of age, nasal samples were much more frequently positive 
than other sample types (Fig. 2), whereas this difference 
was less obvious in the older animals, although the number 
in this group was low. All but one virus-shedding animal 
had a positive nasal swab.
In order to assess possible differences in viral loads for the 
different sample types, samples were arbitrarily grouped on 
the basis of the results of the N gene PCR (the most sensitive 
primer pair) into a low and high viral load category. This 
showed that nasal swabs more frequently had higher viral 
loads (cycle threshold [Ct] 30 or less) (Fig. 3) and the 
highest viral load sample (Ct 11.27) (Fig. 4). 
Discussion
The fact that 79% of the dromedary camels examined 
were found to be positive for MERS-CoV RNA revealed 
the high prevalence of the virus in these animals at the 
time of the study. Further, it reflects the epidemiological 
role that may be played by camels in disease perpetuation, 
given that they are inapparent reservoir hosts of MERS-
CoV. High prevalence and antibody titres have also been 
reported in camels from Oman and Egypt, suggesting 
widespread virus circulation. However, virological testing 
was unable to detect MERS-CoV viral sequences in these 
Fig. 2 
Kinetics of shedding, by sample type, of MERS-CoV from dromedary camels sampled at the Doha slaughterhouse
In total, 19 animals were between 0 and 6 months of age, 20 were between 6 months and 1 year, nine were aged 1–2 years, and five were older 












































 0–6 months 7–12 months 1–2 years >2 years All 95% CI SE
Nasal swab
79% 85% 88.9% 20% 77.4% 
(41 out of 53)
66–88.6 % 0.0574
Oral swab
21% 35% 33.3% 20% 28.3% 
(15 out of 53)
16.2–40.4% 0.0618
Rectal swab
26% 20% 33.3% 0% 22.6% 
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Fig. 3 
Distribution of viral load by sample type
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camels, probably because only faecal and serum samples 
were analysed (3, 5). Definitive evidence that dromedary 
camels can be infected with MERS-CoV was obtained when 
viral sequences were detected in nasal swabs from camels 
sampled in close proximity to outbreaks of the disease 
among humans in Qatar (9). Viral nucleic acids were more 
commonly detected in nasal swabs than in rectal specimens 
in a study done in Saudi Arabia (13). A near-full-genome 
sequence (29,908 nucleotides, >99%) of a virus genetically 
very similar to human MERS-CoV was identified from a 
nasal swab specimen obtained from a dromedary camel in 
Egypt (8). 
In this study, the high percentage of positive samples 
demonstrated by the nasal swabs, giving a sensitivity of 
97.6%, in addition to the more frequent finding of a high 
viral load, shows that nasal swabs are the sample of choice 
for monitoring virus presence using RT-PCR technology in 
apparently healthy camels. This conclusion is supported by 
the fact that sequence analysis of the virus isolated from the 
swab with the highest viral load in this study confirmed the 
presence of MERS-CoV; the virus was closely related to the 
human England/Qatar 1 virus isolated in 2012 in a previous 
study (10). An added advantage is that nasal sampling is 
the simplest of the three sampling methods, requiring least 
restraint of the animals, thereby enhancing acceptability 
and reducing cost. Therefore, for surveillance studies, the 
authors recommend limiting sample collection to nasal 
sampling, in young animals. A caveat is that the pattern of 
shedding may differ in different age groups, as suggested 
by the lower proportion of nasal shedders in animals over 
two years of age in this study. Future studies are needed to 
address this question.
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Résumé
Des travaux de recherche approfondis sont encore nécessaires concernant le 
coronavirus responsable du syndrome respiratoire du Moyen-Orient (MERS-
CoV), un virus identifié récemment et qui provoque des troubles respiratoires 
sévères en particulier chez les individus atteints de pathologies multiples. Les 
études effectuées au Qatar et ailleurs ont démontré que les dromadaires font 
office de réservoirs du virus ; toutefois, les modalités précises de la transmission 
du MERS-CoV à l’être humain demeurent obscures. En février 2014, une équipe de 
chercheurs a évalué l’adéquation et la sensibilité de plusieurs types d’échantillons 
pour détecter le MERS-CoV en utilisant l’amplification en chaîne par polymérase 
couplée à une transcription inverse en temps réel (RT-PCR) spécifique pour 
trois cibles génétiques, à savoir la séquence UpE  (en amont du gène E), le 
gène N (nucléocapside) et le cadre de lecture ORF1a. Pour ce faire, divers 
prélèvements ont été effectués sur 53 dromadaires destinés à l’abattage.  Un fort 
pourcentage de ces dromadaires (79 % [intervalle de confiance à 95 % compris 
entre 66,9 et 91,5 %, erreur standard : 0,0625], soit 42 sur 53) excrétaient le MERS-
CoV au moment de l’abattage, mais aucun ne présentait le moindre signe clinique. 
Les échantillons dans lesquels le plus de cas positifs ont été détectés étaient 
les écouvillons nasaux (97,6 %). Venaient ensuite les écouvillons oraux, qui ont 
détecté 35,7 % de cas positifs, puis les écouvillons rectaux (28,5 % de cas positifs 
détectés). Par ailleurs, ce sont les écouvillons nasaux qui ont permis d’obtenir 
l’intensité la plus élevée de la réponse de la RT-PCR, exprimée en une valeur du 
seuil de cycles de 11,27. Ces résultats permettent de conclure que les écouvillons 
nasaux sont les échantillons à privilégier pour la détection du MERS-CoV par RT-
PCR chez les dromadaires asymptomatiques.
Mots-clés
Amplification en chaîne par polymérase couplée à une transcription inverse en temps réel 
– Coronavirus – Dromadaire – Écouvillon pour prélèvement microbiologique  – Syndrome 
respiratoire du Moyen-Orient.
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Resumen
Es preciso investigar más a fondo el coronavirus del síndrome respiratorio 
de Oriente Medio (MERS-CoV), recién identificado, que provoca una grave 
enfermedad respiratoria, sobre todo en personas con afecciones concomitantes. 
Estudios realizados en Qatar y otros lugares han deparado pruebas de que los 
dromedarios son un reservorio del virus, pero aún no están del todo claros los 
modelos exactos de transmisión del MERS-CoV al ser humano. Los autores 
describen un análisis realizado en febrero de 2014 de la idoneidad y sensibilidad 
de distintos tipos de muestra para detectar el MERS-CoV mediante una reacción 
en cadena de la polimerasa acoplada a transcripción inversa en tiempo real (RT-
PCR) dirigida contra tres genes: el gen UpE (upstream of the E gene: en dirección 
5’ desde el gen E); el gen N (nucleocápside) y el marco de lectura abierto (ORF) 
1a. Para ello se tomaron muestras de 53 animales enviados al sacrificio. Se 
comprobó que un elevado porcentaje de los dromedarios analizados (un 79% 
[intervalo de confianza al 95%: 66,9–91,5%; error estándar: 0,0625], esto es, 
42 de 53) excretaban virus en el momento del sacrificio, pese a que todos los 
animales parecían estar sanos. Entre los ejemplares positivos para el MERS-CoV, 
las muestras que con más frecuencia arrojaban resultado positivo eran los frotis 
nasales (97,6%). Las segundas, por orden de frecuencia, eran los frotis bucales 
(35,7%), seguidos de los frotis rectales (28,5%). Además, la carga viral más alta, 
expresada por un valor de ciclo umbral (Ct) (o punto de cruce) de 11,27, se obtuvo 
a partir de un frotis nasal. Estos resultados llevan a la conclusión de que los frotis 
nasales son el tipo de muestra más adaptado para detectar el MERS-CoV en 
dromedarios aparentemente sanos mediante la técnica de RT-PCR.
Palabras clave 
Coronavirus – Dromedario – Frotis de mucosas – Reacción en cadena de la polimerasa con 
transcripción inversa en tiempo real – Síndrome respiratorio de Oriente Medio.
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